For the good of the patient: risks and benefits of medicines

被引：8
|
作者：
Breckenridge, A [1 ]
机构：
[1] Univ Liverpool, Dept Pharm & Therapeut, Liverpool L69 3BX, Merseyside, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2003年 / 12卷 / 02期
关键词：
medicines; risks; benefits; pharmacovigilance;
D O I：
10.1002/pds.805
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
The basis of regulation of medicines is an assessment of risk and benefit. As the process of drug development has evolved with the advances in scientific knowledge, new and more precise methods of measuring drug efficacy have been created. Pharmacovigilance must also change with as much emphasis being placed on demonstrating the safety of a medicine as on preventing harm. Communication of these issues to interested parties remains problematical with room for considerable improvement. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码：145 / 150
页数：6
相关论文
共 50 条
  • [31] Perceptions of the risks and benefits of medicines in patients with rheumatoid arthritis and other painful musculoskeletal conditions
    Berry, D
    Bradlow, A
    Bersellini, E
    RHEUMATOLOGY, 2004, 43 (07) : 901 - 905
  • [32] The benefits, risks and costs of privacy: patient preferences and willingness to pay
    Trachtenbarg, David E.
    Asche, Carl
    Ramsahai, Shweta
    Duling, Joy
    Ren, Jinma
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (05) : 845 - 851
  • [33] Immunoglobulins: Benefits and risks from the patient's point of view
    Revol, B.
    Bickert, L.
    Sarrot-Reynauld, F.
    Allenet, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 90 - 90
  • [34] Immunoglobulins: Benefits and risks from the patient's point of view
    Revol, Bruno
    Bickert, Laura
    Sarrot-Reynauld, Francoise
    Allenet, Benoit
    THERAPIE, 2017, 72 (06): : 683 - 684
  • [35] Patient knowledge & sources of information about the risks & benefits of NSAIDs
    Arthur, VA
    Jobanputra, P
    Holmes, G
    Pugh, M
    Griffiths, P
    Spannuth, F
    Thomas, E
    Sheeran, T
    Parry, D
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 348 - 348
  • [36] The Benefits and Risks of Being a Standardized Patient: A Narrative Review of the Literature
    Joseph Plaksin
    Joseph Nicholson
    Sarita Kundrod
    Sondra Zabar
    Adina Kalet
    Lisa Altshuler
    The Patient - Patient-Centered Outcomes Research, 2016, 9 : 15 - 25
  • [37] Application of sedative/hypnotics in the patient with pulmonary diseases - benefits or risks?
    Bogaczewicz, Anna
    Zycinska, Katarzyna
    Wardyn, Kazimierz A.
    Hadzik-Blaszczyk, Malgorzata
    Krupa, Renata
    Nitsch-Osuch, Aneta
    Zarzycki, Slawomir
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2011, 13 (02): : 132 - 134
  • [38] Clinician/patient interaction: Communicating the benefits and risks of oral contraceptives
    Davis, A
    Wysocki, S
    CONTRACEPTION, 1999, 59 (01) : 39S - 42S
  • [39] PATIENT KNOWLEDGE & SOURCES OF INFORMATION ABOUT THE RISKS & BENEFITS OF NSAIDs
    Arthur, V.
    Jobanputra, P.
    Holmes, G.
    Pugh, M.
    Griffiths, P.
    Spannuth, F.
    Thomas, E.
    Sheeran, T.
    Parry, D.
    RHEUMATOLOGY, 2003, 42 : 31 - 31
  • [40] The risks and benefits of being a young female adolescent standardised patient
    Blake, KD
    Gusella, J
    Greaven, S
    Wakefield, S
    MEDICAL EDUCATION, 2006, 40 (01) : 26 - 35
12345